Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART). - Wikidata - awgldk - TriplyDB

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).

http://www.wikidata.org/entity/Q33778556

about

Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?

P2860

Q52343879-C8ADAE62-8D62-4FE3-943B-2EC63ED7313D Q54232638-C4AB9FA2-908E-44D2-BCEB-462E39531EA0

P2860

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).

http://www.wikidata.org/entity/Q33778556

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@ast

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@en

type

label

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@ast

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@en

prefLabel

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@ast

Genetic polymorphisms associat ...... antiretroviral therapy (cART).

@en

P1433

Q33778556-9950B302-E407-4F0F-AB03-B10EABD871FE

P1476

Q33778556-1F7C91F2-7392-473D-B706-1725D8CFC34A

P2093

Q33778556-1B99B993-40E2-42D6-A51E-D513FE576C5C

Q33778556-278EBD39-B835-46B0-BBF8-3A5612CEF9AF

Q33778556-548BA961-9A32-49C9-8E70-57265AC0CFA4

Q33778556-8E765488-F4E7-4037-B2E3-C4AFE6500747

Q33778556-B24FBD02-514D-41CE-9AF3-380E02FD4D48

Q33778556-BA382CAF-06CC-4A1A-BEB4-12ABFFE46997

Q33778556-DC452130-76D6-416D-B657-CFCEA074CD0B

Q33778556-EB6F257C-D0E3-40AA-B797-74005E930475

Q33778556-F36187FE-C505-47D8-BA6F-D923ADCF9FC6

P2860

Q33778556-038E800A-C1B0-417E-8460-DD486F2E2E78

Q33778556-106B0CEF-8BBA-4A56-B2FE-F264F61FA823

Q33778556-14BB0182-60AC-4FE6-9A65-10C4CB77EB7D

Q33778556-22062BC3-CD1E-4C96-9551-980679C79E3D

Q33778556-22B54761-3C39-45AB-9961-C7780A96B9BA

Q33778556-2AB37E27-1568-4DD8-A2A4-CD2169030D39

Q33778556-2CCBCB8F-0614-4DFC-BA25-71A867AE5E03

Q33778556-3039E9BD-D194-4F2C-9C3B-BEF3B5F22D26

Q33778556-311E79D1-464C-4A61-9ACF-695CA8CA1F95

Q33778556-332C4657-F0E6-48E5-AF70-721301A3CEBF

P304

Q33778556-DCE1E68D-8D54-4FA6-B690-1684B66DBDE3

P31

Q33778556-6C56578E-DE5E-4680-972C-C778274F405C

P356

Q33778556-20436BE5-FF66-4C5F-84F6-4D9AE8C76979

P407

Q33778556-73C7939D-6692-456D-AF88-3D13508B535C

P433

Q33778556-23EE0DA0-AA4A-4CD2-A391-F713B03F4D2F

P478

Q33778556-6508BCAB-0F0E-4CEA-9476-E1F53CC03CCA

P50

Q33778556-5B6315DF-79E5-40CD-AE31-FF7B35AB593C

Q33778556-73426B7B-524B-4302-B704-E025C0EEDA66

Q33778556-D513E868-49E6-48EA-B75B-A0247F62B5E9

Q33778556-D83A448B-8C1B-438F-B724-A7F084513DC6

P577

Q33778556-90EDFA49-471C-41A3-A3D1-F8B8A776F31F

P698

Q33778556-FA08D335-D8A9-4C63-B941-BD51CD313AAC

P921

Q33778556-24B66EE9-514F-4D51-862F-2E74F5BFA242

P932

Q33778556-483FD6BF-F087-440B-AF0C-51939D539DB9

P356

JOURNAL.PONE.0178685

P1433

P1476

Genetic polymorphisms associat ...... antiretroviral therapy (cART)

@en

P2093

Carolin Luda

http://www.w3.org/2001/XMLSchema#string

Carolynne Schwarze-Zander

http://www.w3.org/2001/XMLSchema#string

Christian P Strassburg

http://www.w3.org/2001/XMLSchema#string

Christoph Boesecke

http://www.w3.org/2001/XMLSchema#string

Cordula Hansel

http://www.w3.org/2001/XMLSchema#string

Jan-Christian Wasmuth

http://www.w3.org/2001/XMLSchema#string

Jonel Trebicka

http://www.w3.org/2001/XMLSchema#string

Jürgen Kurt Rockstroh

http://www.w3.org/2001/XMLSchema#string

Ulrich Spengler

http://www.w3.org/2001/XMLSchema#string

P2860

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.

P304

e0178685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0178685

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Hans Dieter Nischalke

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28594920

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5464588

http://www.w3.org/2001/XMLSchema#string